In recent years, research has brought more evidence of how CCR9/CCL25 contributes to inflammation, which are associated with several diseases, including cardiovascular disease (CVD), hepatitis, arthritis [50], inflammatory bowel disease [51], and asthma. This evidence concerns the gene CCR9 and arthritic joint disease.